178 related articles for article (PubMed ID: 19585361)
1. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
Bhat P; Cervantes-Castañeda RA; Doctor PP; Anzaar F; Foster CS
Ocul Immunol Inflamm; 2009; 17(3):185-90. PubMed ID: 19585361
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Deuter C
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil in the treatment of uveitis in children.
Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M
Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
Sobrin L; Christen W; Foster CS
Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil in the treatment of ocular inflammation in ANCA-associated vasculitis.
Yalçindağ FN; Amer R; Forrester JV
J Ocul Pharmacol Ther; 2008 Apr; 24(2):249-54. PubMed ID: 18321200
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil therapy for inflammatory eye disease.
Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil for ocular inflammation.
Daniel E; Thorne JE; Newcomb CW; Pujari SS; Kaçmaz RO; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Foster CS; Jabs DA; Kempen JH
Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
[TBL] [Abstract][Full Text] [Related]
8. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
Greiner K; Varikkara M; Santiago C; Forrester JV
Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil for the treatment of uveitis.
Teoh SC; Hogan AC; Dick AD; Lee RW
Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
Siepmann K; Huber M; Stübiger N; Deuter C; Zierhut M
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
Lau CH; Comer M; Lightman S
Clin Exp Ophthalmol; 2003 Dec; 31(6):487-91. PubMed ID: 14641155
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.
Androdias G; Maillet D; Marignier R; Pinède L; Confavreux C; Broussolle C; Vukusic S; Sève P
Neurology; 2011 Mar; 76(13):1168-72. PubMed ID: 21444902
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine Therapy in Sarcoidosis-Associated Uveitis.
Bert A; El Jammal T; Kodjikian L; Gerfaud-Valentin M; Jamilloux Y; Seve P
Ocul Immunol Inflamm; 2024 Feb; 32(2):154-160. PubMed ID: 36749910
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
Cuchacovich M; Solanes F; Perez C; Verdaguer JI; Verdaguer J; Castiglione E; Carpentier C; Traipe L; Villarroel F
J Ocul Pharmacol Ther; 2016; 32(1):55-61. PubMed ID: 26562247
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil monotherapy in the management of paediatric uveitis.
Chang PY; Giuliari GP; Shaikh M; Thakuria P; Makhoul D; Foster CS
Eye (Lond); 2011 Apr; 25(4):427-35. PubMed ID: 21423146
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil in the therapy of uveitic macular edema--long-term results.
Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Deuter C
Ocul Immunol Inflamm; 2012 Jun; 20(3):203-11. PubMed ID: 22489750
[TBL] [Abstract][Full Text] [Related]
17. [Mycophenol acid in ocular automimmune disorders--can we optimise this therapy?].
Pleyer U; Ruokonen P; Schmidt N; Feist E; Höhne M; Stanojlovic S
Klin Monbl Augenheilkd; 2008 Jan; 225(1):66-9. PubMed ID: 18236373
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
Galor A; Jabs DA; Leder HA; Kedhar SR; Dunn JP; Peters GB; Thorne JE
Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.
Li J; Kelly R
J Am Acad Dermatol; 2013 Oct; 69(4):565-9. PubMed ID: 23850090
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate Mofetil for the Treatment of Multiple Sclerosis-associated Uveitis.
Hedayatfar A; Falavarjani KG; Soheilian M; Elmi Sadr N; Modarres M; Parvaresh MM; Naseripour M; Rohani M; Almasi M; Chee SP
Ocul Immunol Inflamm; 2017 Jun; 25(3):308-314. PubMed ID: 27379567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
